Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8273 | 1272 | 45.8 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
854 | 2 | CD40//BAFF//CD40 LIGAND | 11643 |
8273 | 1 | BAFF//APRIL//BLYS | 1272 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BAFF | authKW | 3013587 | 16% | 62% | 202 |
2 | APRIL | authKW | 2066573 | 9% | 79% | 109 |
3 | BLYS | authKW | 1146287 | 5% | 71% | 67 |
4 | BAFF R | authKW | 693222 | 3% | 76% | 38 |
5 | B CELL ACTIVATING FACTOR | authKW | 666577 | 4% | 51% | 54 |
6 | B LYMPHOCYTE STIMULATOR | authKW | 630854 | 2% | 91% | 29 |
7 | TACI | authKW | 553155 | 3% | 59% | 39 |
8 | BELIMUMAB | authKW | 547530 | 4% | 48% | 48 |
9 | A PROLIFERATION INDUCING LIGAND | authKW | 523437 | 2% | 84% | 26 |
10 | BCMA | authKW | 365017 | 2% | 72% | 21 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 9285 | 41% | 0% | 524 |
2 | Rheumatology | 7351 | 14% | 0% | 178 |
3 | Hematology | 862 | 9% | 0% | 110 |
4 | Cell Biology | 284 | 10% | 0% | 122 |
5 | Medicine, Research & Experimental | 258 | 6% | 0% | 82 |
6 | Oncology | 134 | 7% | 0% | 95 |
7 | Biochemistry & Molecular Biology | 118 | 13% | 0% | 161 |
8 | Allergy | 97 | 1% | 0% | 19 |
9 | Pharmacology & Pharmacy | 87 | 8% | 0% | 96 |
10 | Biotechnology & Applied Microbiology | 45 | 4% | 0% | 52 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JIANGSU PROV MOL MED BIOTECHNOL | 247933 | 4% | 23% | 45 |
2 | LOUIS JEANTET | 54008 | 0% | 75% | 3 |
3 | ARTHRITIS INFLAMMAT | 50825 | 0% | 35% | 6 |
4 | ALLERGY NEVE OR AIDS | 48008 | 0% | 100% | 2 |
5 | CHU AUGUSTIN MORVAN | 48008 | 0% | 100% | 2 |
6 | CORNELL ROCKEFELLER UNIV SLOAN KETTERING TRI | 48008 | 0% | 100% | 2 |
7 | HOP ST LOUIS HEMATOL IMMUNOPATHOL | 48008 | 0% | 100% | 2 |
8 | HUBEI PROV BIOTECHNOL TCM | 48008 | 0% | 100% | 2 |
9 | ANTIINFLAMMATORY IMMUNOPHARMACOL | 34096 | 1% | 16% | 9 |
10 | ANTIBODY DISCOVERY DEV | 32004 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF IMMUNOLOGY | 2846 | 6% | 0% | 81 |
2 | ARTHRITIS RESEARCH & THERAPY | 2354 | 1% | 1% | 18 |
3 | ARTHRITIS AND RHEUMATISM | 2202 | 2% | 0% | 31 |
4 | SEMINARS IN IMMUNOLOGY | 2187 | 1% | 1% | 9 |
5 | EXPERT OPINION ON BIOLOGICAL THERAPY | 1918 | 1% | 1% | 13 |
6 | LUPUS | 1824 | 1% | 0% | 17 |
7 | ANNALS OF THE RHEUMATIC DISEASES | 1786 | 2% | 0% | 26 |
8 | NATURE REVIEWS RHEUMATOLOGY | 1660 | 0% | 1% | 6 |
9 | BLOOD | 1540 | 4% | 0% | 48 |
10 | RHEUMATOLOGY | 1452 | 1% | 0% | 17 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BAFF | 3013587 | 16% | 62% | 202 | Search BAFF | Search BAFF |
2 | APRIL | 2066573 | 9% | 79% | 109 | Search APRIL | Search APRIL |
3 | BLYS | 1146287 | 5% | 71% | 67 | Search BLYS | Search BLYS |
4 | BAFF R | 693222 | 3% | 76% | 38 | Search BAFF+R | Search BAFF+R |
5 | B CELL ACTIVATING FACTOR | 666577 | 4% | 51% | 54 | Search B+CELL+ACTIVATING+FACTOR | Search B+CELL+ACTIVATING+FACTOR |
6 | B LYMPHOCYTE STIMULATOR | 630854 | 2% | 91% | 29 | Search B+LYMPHOCYTE+STIMULATOR | Search B+LYMPHOCYTE+STIMULATOR |
7 | TACI | 553155 | 3% | 59% | 39 | Search TACI | Search TACI |
8 | BELIMUMAB | 547530 | 4% | 48% | 48 | Search BELIMUMAB | Search BELIMUMAB |
9 | A PROLIFERATION INDUCING LIGAND | 523437 | 2% | 84% | 26 | Search A+PROLIFERATION+INDUCING+LIGAND | Search A+PROLIFERATION+INDUCING+LIGAND |
10 | BCMA | 365017 | 2% | 72% | 21 | Search BCMA | Search BCMA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STOHL, W , (2014) THERAPEUTIC TARGETING OF THE BAFF/APRIL AXIS IN SYSTEMIC LUPUS ERYTHEMATOSUS.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 18. ISSUE 4. P. 473-489 | 148 | 84% | 21 |
2 | VINCENT, FB , SAULEP-EASTON, D , FIGGETT, WA , FAIRFAX, KA , MACKAY, F , (2013) THE BAFF/APRIL SYSTEM: EMERGING FUNCTIONS BEYOND B CELL BIOLOGY AND AUTOIMMUNITY.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 24. ISSUE 3. P. 203 -215 | 108 | 77% | 82 |
3 | MACKAY, F , SILVEIRA, PA , BRINK, R , (2007) B CELLS AND THE BAFF/APRIL AXIS: FAST-FORWARD ON AUTOIMMUNITY AND SIGNALING.CURRENT OPINION IN IMMUNOLOGY. VOL. 19. ISSUE 3. P. 327-336 | 90 | 87% | 157 |
4 | DILLON, SR , GROSS, JA , ANSELL, SM , NOVAK, AJ , (2006) AN APRIL TO REMEMBER: NOVEL TNF LIGANDS AS THERAPEUTIC TARGETS.NATURE REVIEWS DRUG DISCOVERY. VOL. 5. ISSUE 3. P. 235-246 | 84 | 86% | 199 |
5 | VINCENT, FB , MORAND, EF , SCHNEIDER, P , MACKAY, F , (2014) THE BAFF/APRIL SYSTEM IN SLE PATHOGENESIS.NATURE REVIEWS RHEUMATOLOGY. VOL. 10. ISSUE 6. P. 365 -373 | 72 | 72% | 54 |
6 | WEI, F , CHANG, Y , WEI, W , (2015) THE ROLE OF BAFF IN THE PROGRESSION OF RHEUMATOID ARTHRITIS.CYTOKINE. VOL. 76. ISSUE 2. P. 537 -544 | 82 | 86% | 1 |
7 | RYAN, MC , GREWAL, IS , (2009) TARGETING OF BAFF AND APRIL FOR AUTOIMMUNITY AND ONCOLOGY.THERAPEUTIC TARGETS OF THE TNF SUPERFAMILY. VOL. 647. ISSUE . P. 52-63 | 87 | 93% | 10 |
8 | TREML, JF , HAO, Y , STADANLICK, JE , CANCRO, MP , (2009) THE BLYS FAMILY: TOWARD A MOLECULAR UNDERSTANDING OF B CELL HOMEOSTASIS.CELL BIOCHEMISTRY AND BIOPHYSICS. VOL. 53. ISSUE 1. P. 1-16 | 106 | 68% | 38 |
9 | UZZAN, M , COLOMBEL, JF , CERUTTI, A , TRETON, X , MEHANDRU, S , (2016) B CELL-ACTIVATING FACTOR (BAFF)-TARGETED B CELL THERAPIES IN INFLAMMATORY BOWEL DISEASES.DIGESTIVE DISEASES AND SCIENCES. VOL. 61. ISSUE 12. P. 3407 -3424 | 108 | 59% | 0 |
10 | MACKAY, F , SCHNEIDER, P , (2009) CRACKING THE BAFF CODE.NATURE REVIEWS IMMUNOLOGY. VOL. 9. ISSUE 7. P. 491 -502 | 67 | 63% | 330 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 16606 | PRDM1//BLIMP 1//PLASMA CELLS |
2 | 5381 | RECEPTOR EDITING//SURROGATE LIGHT CHAIN//PRE B CELL RECEPTOR |
3 | 2712 | LUPUS NEPHRITIS//SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS |
4 | 12463 | REGULATORY B CELLS//B10 CELLS//BREGS |
5 | 21324 | TWEAK//FN14//STWEAK |
6 | 17952 | TRAF4//TRAF6//TRAF2 |
7 | 10461 | IRF5//GENOM INVEST ONCOL GENYO//INTERFERON REGULATORY FACTOR 5 |
8 | 9035 | B 1 CELLS//CD5 B CELLS//B 1A CELLS |
9 | 3006 | COMMON VARIABLE IMMUNODEFICIENCY//IGA DEFICIENCY//CVID |
10 | 2646 | SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//RHEUMATOLOGY |